| Analysis | Metabolite Name | Measured Value | Units | Sample type | Gender |
|---|---|---|---|---|---|
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 23412 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 26432 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 26706 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 33431 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 37950 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 38794 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 41203 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 42573 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 47694 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 49231 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 49523 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 52263 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 52376 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 53015 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 56041 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 60761 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 61394 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 62280 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 62908 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 63332 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 63726 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 63918 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 65437 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 66720 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 67511 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 68661 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 69392 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 70621 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 71338 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 75331 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 76843 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 78076 | Peak area normalized | red cross plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 82206 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 83357 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 83393 | Peak area normalized | chear plasma | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 133139 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 228479 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 231302 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 287618 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 289504 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1411571 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1449652 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1465440 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1561145 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1565493 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1603431 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1665273 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1721872 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1729193 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1825552 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1853224 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1894818 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 1928993 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2083872 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2089990 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2124093 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2153950 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2194383 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2206024 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2211900 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2231009 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2287082 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2289552 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2296615 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2331364 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2346038 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2369183 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2443568 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2458911 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2462389 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2497072 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2509398 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2513688 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2519818 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2538492 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2551674 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2561387 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2665513 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2666349 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2677440 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2701107 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2707412 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2734119 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2737475 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2746394 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2780150 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2791440 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2801091 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2816427 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2818972 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2819886 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2821205 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2826456 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2835289 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2835472 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2841986 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2843268 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2890954 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2918331 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2936400 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2957835 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2983807 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2989412 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2991087 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2991170 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2991253 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 2992928 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3025970 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3026612 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3049279 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3066978 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3074921 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3076126 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3078606 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3082246 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3084022 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3089167 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3105316 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3117261 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3128088 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3130928 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3135044 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3137066 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3167059 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3169773 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3205089 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3217586 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3234895 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3235552 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3250189 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3259327 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3287705 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3321044 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3340317 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3392507 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3457805 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3459882 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3467250 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3479783 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3497113 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3500627 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3521671 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3531727 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3534943 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3542021 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3543613 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3577539 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3588672 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3593914 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3604031 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3607530 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3661652 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3661692 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3673362 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3686240 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3690767 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3702867 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3709986 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3722280 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3740946 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3756237 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3759496 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3770371 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3788101 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3795900 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3796032 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3805370 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3808755 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3815671 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3819961 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3827372 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3831448 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3834898 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3836041 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3836437 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3839308 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3839414 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3843025 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3844205 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3844628 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3844830 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3851226 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3851780 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3852184 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3858702 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3860381 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3861460 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3862716 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3864433 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3866866 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3869958 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3873079 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3873381 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3874816 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3876251 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3876553 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3877275 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3877461 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3878022 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | FA(9:0-COOH) | 3880085 | Peak area normalized | batch pool | - |
Return to search page
